IS THERE A MORTALITY BENEFIT WITH RENIN-ANGIOTENSIN SYSTEM (RAS) INHIBITION IN AFRICAN AMERICANS (AA) WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF)?

Ravinder R Valadri,Emir Veledar,Radhika R Gadesam,Saumeth Cardona,Jo Ann Cross,Gregory Strayhorn,Heather L Bloom,Adefisayo Oduwole,David De Lurgio,Javed Butler,Elizabeth Ofili,Anekwe E Onwuanyi

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2012）

引用 0|浏览19

暂无评分

摘要

RAS inhibitors (RASIs/ACE inhibitors & ARBs) have reduced mortality in SHF (EF 45p) in randomized controlled trials. Since, AAs are underrepresented in these trials, whether these results are applicable to AAs with HFPEF is uncertain All cause mortality was

查看译文

关键词

Treatment

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要